Researchers employ P21 to mimic select CNTF activities, promoting enhanced neurogenesis and synaptic integrity without full-length CNTF limitations in experimental systems. Pre-clinical observations in mouse models indicate increased dentate gyrus progenitor commitment, newborn neuron maturation, and synaptic marker expression following peripheral administration.
This tetrapeptide facilitates investigation of neurotrophic cascades influencing neuronal survival, dendritic architecture, and adaptive responses in hippocampal networks.
Scientific Overview of P21 Applications
Pre-clinical models highlight P21’s engagement with neurotrophic pathways:
- Enhancement of dentate gyrus neurogenesis and maturation of newborn neurons in the granular and subgranular zones of rodent hippocampus. https://pubmed.ncbi.nlm.nih.gov/20600002/
- Upregulation of BDNF expression leading to increased synaptic protein levels and plasticity markers in cortical and hippocampal neurons. https://pubmed.ncbi.nlm.nih.gov/39592934/
- Modulation of GSK-3β activity via BDNF-mediated inhibitory phosphorylation, contributing to reduced tau hyperphosphorylation in neurodegeneration models. https://pubmed.ncbi.nlm.nih.gov/27400746/ (review context)
- Rescue of synaptic deficits and dendritic abnormalities in transgenic models of familial AD-like pathology. https://pubmed.ncbi.nlm.nih.gov/28655344/
- Support for investigations into early developmental neurotrophic support preventing later cognitive and synaptic impairments in transgenic systems. https://pubmed.ncbi.nlm.nih.gov/34057082/
- Promotion of neuronal plasticity and cognitive performance markers in normal and aging rodent models without apparent adverse effects.
For broader insights into CNTF-derived mimetics and neurotrophic signaling in neurodegeneration research, refer to the Peptide Sciences or About Peptides sections.
Why Investigators Select National Science Labs P21
National Science Labs manufactures P21 under rigorous GMP-compliant protocols to ensure batch consistency and reliability for pre-clinical experiments. Independent third-party testing verifies each lot for:
- Purity ≥99.9% by HPLC
- Structural identity confirmation
- Complete Certificate of Analysis (CoA) documentation provided per batch
For Research Use Only. This product is supplied exclusively for in vitro and in vivo pre-clinical research by qualified investigators. Statements about this peptide have not been evaluated by the FDA.
Initiate Your P21 Research Protocol
Source high-purity P21 from current limited batches to ensure optimal stability and performance in neurotrophic signaling and hippocampal neurogenesis studies.
